Skip to main content

Compliance & Enforcement

RA 9711 ยท CDRRHR enforcement authority ยท Bureau of Customs ยท Regional Field Offices

CDRRHR Inspection Authorityโ€‹

CDRRHR has authority to inspect:

  • Importer and distributor facilities
  • Retail outlets
  • Healthcare facility storage and use areas
  • Manufacturing facilities (Philippines-based)

CDRRHR inspectors may:

  • Request all registration and licence documents
  • Sample products for testing
  • Review distribution records
  • Inspect storage conditions
  • Assess labelling compliance

FDA Philippines Enforcement Actionsโ€‹

ActionAuthority
Product recallOrder or coordinate recall of non-compliant or unsafe devices
CMDN/CMDR suspensionSuspend certificate pending investigation
CMDN/CMDR cancellationCancel certificate for persistent non-compliance or safety issues
LTO suspensionSuspend operations licence
LTO revocationRevoke operations licence
Product seizure and condemnationSeize and destroy unregistered or unsafe devices
FinesIssue fines under RA 9711
Criminal prosecutionRefer serious violations for criminal prosecution

Prohibited Acts Under RA 9711 and AO 2018-002โ€‹

The following are prohibited:

  • Commercial distribution of unregistered devices (Class A without CMDN; Class B/C/D without CMDR)
  • Distribution without a valid LTO
  • Falsification or alteration of CMDN or CMDR certificates โ€” PH-Unique criminal provision
  • Misrepresentation of device classification
  • Distribution of devices that do not match the registered specifications
  • Failure to comply with a CDRRHR recall order

Falsification of CMDN/CMDR โ€” PH-Uniqueโ€‹

RA 9711 includes specific criminal provisions for falsification or alteration of CMDN or CMDR certificates. This is treated as a serious offence โ€” beyond the civil/administrative penalties available for other violations โ€” and can result in criminal prosecution.

Bureau of Customs Coordination โ€” PH-Uniqueโ€‹

The Bureau of Customs (BoC) coordinates with CDRRHR to intercept unregistered medical devices at the point of importation:

  • CDRRHR and BoC have a coordinated list of devices requiring valid CMDN/CMDR for customs clearance
  • Shipments lacking valid registration documentation may be detained, seized, or returned
  • The importer must provide evidence of valid CMDN/CMDR and LTO for customs release of registered device shipments

Practical implication: Ensure all customs documentation includes the CMDN/CMDR number and the LTO reference. Do not ship without confirmed valid registrations.

Regional Field Offices โ€” PH-Uniqueโ€‹

FDA Philippines operates Regional Field Offices throughout the Philippines (outside Metro Manila), which conduct:

  • Local compliance monitoring
  • Market surveillance sampling
  • Inspection of regional importers and distributors
  • Consumer complaint investigations
  • Coordination with local government units

Geographic reach: Unregistered device distribution is monitored not only in Metro Manila but throughout the archipelago via these regional offices.

Motion for Reconsideration and Appeal โ€” PH-Uniqueโ€‹

Under RA 9711, a party aggrieved by a CDRRHR decision (e.g., application disapproval, LTO revocation) may:

  1. File a Motion for Reconsideration with the FDA Director General within the prescribed period
  2. Appeal to the Court of Appeals after exhausting administrative remedies
  3. Further appeal to the Supreme Court on questions of law

This formal appeal process distinguishes Philippines' framework from many other ASEAN markets.

Confidentiality of Submitted Information โ€” PH-Uniqueโ€‹

RA 9711 includes provisions on the confidentiality of technical data submitted to FDA Philippines. Proprietary information (formulation details, manufacturing processes, clinical data) submitted for registration purposes is protected from unauthorised disclosure. The FDA may use the information for regulatory evaluation but cannot share it with third parties without the applicant's consent, subject to certain public health exceptions.